Navigation Links
Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance
Date:1/23/2008

retirement date. If payments exceed the sum of service and interest cost components of net periodic pension cost of the plan for the fiscal year, settlement accounting is triggered under pension accounting rules. However, a settlement loss may not be recognized until the time the pension obligation is settled. The Company recognized $10.3 for settlement losses in the fourth quarter of 2007 and an additional $1.4 in the first quarter of 2008, based on cash payments made. The Company expects to recognize an additional $25 to $30 for settlement losses in 2008, primarily in the second quarter. This additional charge pertains to 2007 and announced 2008 retirements. The actual amount of the settlement loss will be based upon current pension assumptions (e.g. discount rate) at the time cash payments are made to settle the obligations.

4. SHARE REPURCHASE PROGRAM

On 20 September 2007, the Board of Directors authorized the repurchase of up to $1,000 of the Company's outstanding common stock. This action was in addition to an existing $1,500 share repurchase authorization which was announced in March 2006. As of 30 September 2007, the Company had purchased 5.0 million of its outstanding shares at a cost of $1,063.4 under these two authorizations. During the first quarter of fiscal year 2008, the Company purchased 2.0 million of its outstanding shares at a cost of $189.8. The Company will continue to purchase shares under these authorizations at its discretion while maintaining sufficient funds for investing in its businesses and growth opportunities.

5. BUSINESS SEGMENTS

Previously, the Company reported results for the Chemicals segment, which consisted of the Polymer Emulsions business and the Polyurethane Intermediates (PUI) business. Beginning with the first quarter of 2008, the Polymer Emulsions business has been accounted for as discontinued operations as discussed in Note 2. Also beginning with the first quarter of 2008, the PUI business is r
'/>"/>

SOURCE Air Products
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Makers of OTC Cough Medicines Reaffirm Efficacy of Products
2. DSS Announces Market Research Program for the Design of 2009 MA and PDP Products and Marketing Programs
3. Jan Marini Skin Research Suspends Sales of Popular Eyelash Products
4. Fusion Energy Teams Up With BPs am/pm Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution
5. U.S. Food Safety: A Grocery List of Tainted Products
6. Statement From the Consumer Healthcare Products Association on the SAMHSA Findings on Cough Medicine Abuse
7. Align Technology Previews New Invisalign Products at JPMorgan Healthcare Conference
8. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
9. Stress reduction products and services that are effective and safe
10. New ingredients in drug-like anti-aging products improve skin
11. Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...STANFORD, Calif. A new study shows that muscle ce...ility to squeeze shut properly. The work, performe...tients with conditions such as gastric reflux and ... to strengthen sphincters, which are the bands of ...testinal tract. Weakness in these areas can cause ...
(Date:12/4/2009)...e, MD "Why is it that men can be bastards and wo... Hecht Schafran. The answer, according to an artic...rpretation of facial expressions. , In two studi... of a series of faces. In the first study, androgy...ngry expressions) were more likely to be identifie...
(Date:12/4/2009)...ponse to pressure from federal regulators to crack... FRIDAY, Dec. 4 (HealthDay News) -- The makers of ...esented federal regulators with plans to curb the ...cal companies have been under pressure from U.S. F...y to stop the hundreds of fatal overdoses that occ...
(Date:12/4/2009)...e H1N1 virus will come back during winter isn,t kn...thDay News) -- The number of states reporting wide...s week -- to 25 from a high of 48 just two weeks a...hile, the supply of H1N1 swine flu vaccine continu... the U.S. Centers for Disease Control and Preventi...
(Date:12/4/2009)...y found they spurred blood vessel growth after hea...News) -- Adult stem cells appear to help repair he...se 1 study of 53 patients found that stem cells fr...ood vessels in heart tissue damaged by heart attac...ions within 10 days of having a heart attack. Duri...
Breaking Medicine News(10 mins):Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Swine Flu Continues to Wane 2
...,Corporation (NYSE: SYK ) announced today that it...ence: September 25, 2007 - 4:30 p.m. Eastern Time...ew York A simultaneous webcast of the Company,s p...l be archived for 30 days. Certain statements mad...
...edited for removing requirement for,"dangerousness...vich has signed Senate Bill 234 into law, to the e... improve the state,s strict mental illness,treatme...ss treatment. The new law, which will go into effe...
...anning Corporation,today announced the introductio...ic derivative of its patented GlobalTrak(R) asset ...the rigorous tracking and monitoring,requirements ...anufacturer to distributor to retailer or,clinical...
...cs,Corporation (Nasdaq: DYNT ) today announced re... June 30, 2007. Net income for the fourth quarter,...o $39,101 ($.00 per,share) in the fourth quarter o...ere $17,837,104, compared to,$19,513,136 in the pr...
... examines various state initiatives to expand acce...e President and Congress in support of state effor...of Physicians (ACP). , The paper, State Experim...f state efforts to reform health care and recommen...
...ard of,directors of Abbott today declared a quarte... marks the 335th consecutive quarterly dividend to...s payable Nov. 15, 2007, to,shareholders of record... development, manufacture and marketing of pharmac...
Other Medicine News:Health News:Stryker to Present at Investor Conference 2Health News:Gov. Blagojevich Signs Bill Improving Illinois' Mental Illness Treatment Law 2Health News:System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 2Health News:Dynatronics Announces Strong Fourth Quarter Profit 2Health News:Dynatronics Announces Strong Fourth Quarter Profit 3Health News:Internal medicine physicians recommend key elements to guide state initiatives 2Health News:Internal medicine physicians recommend key elements to guide state initiatives 3
(Date:12/3/2009)...wire-FirstCall/ -- Allen Medical Systems, a subsid...day announced the launch of its new Allen Amatech(... website www.AllenAmatech.com . ,, The webs...y and includes an online version of the new produc...pecifications for the products. "We hope to make t...
(Date:12/3/2009)...wire-FirstCall/ -- A genetic variation that may in...y life-threatening blood disorder if exposed to ce... of several medical discoveries scientists at canc...GX ) will present during the 51st American Society..., December 5-8, 2009, in New Orleans, LA. ,, I...
(Date:12/3/2009)... Ted Karkus, Chairman and... www.quigleyco.com announced today that the Compa...es to develop prescription pharmaceutical and OTC ...interests to focus primarily on the OTC/Personal C...ited to its Cold-EEZE® and Kids-EEZE® br...
Breaking Medicine Technology:Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Depression Anxiety Bad for the Heart 50336 1Depression Anxiety Bad for the Heart 50336 2Depression Anxiety Bad for the Heart 50336 3Cinergy Health Commentary on Americas Prescription Addiction 50331 1Cinergy Health Commentary on Americas Prescription Addiction 50331 2Orthopedic Surgeon Dr Marc W Hungerford a Leading Expert in Field of Avascular Necrosis Now at Baltimore 26apos 3Bs Mercy Medical Center 50326 1Orthopedic Surgeon Dr Marc W Hungerford a Leading Expert in Field of Avascular Necrosis Now at Baltimore 26apos 3Bs Mercy Medical Center 50326 2Orthopedic Surgeon Dr Marc W Hungerford a Leading Expert in Field of Avascular Necrosis Now at Baltimore 26apos 3Bs Mercy Medical Center 50326 3
...Pharmaceuticals, a division of Wyeth (NYSE: WYE )...INvestigation of TORISEL and Avastin,Combination T... phase 3b,study comparing TORISEL(R) (temsirolimus...s interferon-alfa for first-line treatment of pati...th Research is conducting the,INTORACT study with ...
... Important Factor When Selecting Treatment ... - ABSTRACT No: 5110 (Poster 6H), BASEL, S...oncology meeting in the world, the American Societ...s of managing side effects in patients,with metast...ib (Sutent(R)),are two to three times greater than...
Other Medicine Technology:Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 2Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 3Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 4Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 5Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 6Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 2Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 3
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: